Science 37 Holdings, Inc. (NASDAQ:SNCE) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET
Company Participants
Caroline Paul - Investor Relations
David Coman - Chief Executive Officer
Mike Zaranek - Chief Financial Officer
Conference Call Participants
Charles Rhyee - Cowen
Justin Lin - William Blair
Matt Hewitt - Craig-Hallum
Frank Takkinen - Lake Street
Operator
Hello, thank you for standing by and welcome to the Science 37 Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Caroline Paul, Investor Relations. Please go ahead.
Caroline Paul
Thank you and thank you all for participating in today’s call. Joining me are David Coman, Chief Executive Officer; and Mike Zaranek, Chief Financial Officer. Earlier today, Science 37 released financial results for the quarter ended June 30, 2022. A copy of the press release is available on the company’s website.
Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon our current estimates and various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. We encourage you to review our filings made with the Securities and Exchange Commission for a discussion of these risk factors, including our quarterly report on Form 10-Q for the quarter ended June 30, 2022 which was filed earlier today. You are cautioned not to place undue reliance on these forward-looking statements which we speak only as of today and the company disclaims any obligation to update such statements for new information.
We believe that certain non-GAAP metrics are useful in evaluating our operational performance. We use these non-GAAP measures to evaluate our ongoing operations and for internal planning and forecasting purposes. Information about non-GAAP financial measures referenced, including a reconciliation of those measures to the most comparable GAAP measures can be found in our SEC filings and the earnings materials available on the Investor Relations portion of our website at investors.science37.com.
I would now like to turn the call over to David Coman.